Building the next generation of ADCs

Using lightning-fast drug candidate generation and
high-throughput phenotypic screening, we discover hidden synergies to improve antibody-drug conjugates.

Get in Touch

Our Solution

Multidimensional
Drug Discovery:
‍LiliumX™ Platform

Learn More About Our Technology

Rapid Design

Our LiliumX™ Platform can rapidly and iteratively build libraries of drug candidates from a variety of components, including antibody fragments and small molecules.

Innovative Drug Candidates

We generate more powerful drug candidates across multiple fields of next-generation antibody engineering, creating unique synergies.

Better Treatments

We focus on treating solid tumours with bispecific antibody-drug conjugates. Aiming at two cellular markers at once to differentiate malignant from healthy tissue enables us to deliver drugs more specifically and effectively.

Noteworthy